Invention Grant
US09399679B2 Therapeutic anti-TIRC7 antibodies for use in immune related and other diseases
有权
治疗性抗TIRC7抗体用于免疫相关疾病和其他疾病
- Patent Title: Therapeutic anti-TIRC7 antibodies for use in immune related and other diseases
- Patent Title (中): 治疗性抗TIRC7抗体用于免疫相关疾病和其他疾病
-
Application No.: US13725535Application Date: 2012-12-21
-
Publication No.: US09399679B2Publication Date: 2016-07-26
- Inventor: Nalan Utku
- Applicant: Nalan Utku
- Agency: Saliwanchik, Lloyd & Eisenschenk
- Priority: EP01130730 20011221
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/28 ; A61K45/06 ; C07K7/00 ; C07K14/00 ; A61K39/00
Abstract:
Provided are specific antibodies against T-cell immune response cDNA7 (TIRC7) costimulatory molecule, which are capable of inhibiting proliferation of peripheral blood mononuclear cells (PBMCs). In particular, high affinity monoclonal and chimeric anti-TIRC7 antibodies are described. Compositions comprising such antibodies and their use for the treatment of immune diseases are provided.
Public/Granted literature
- US20130323254A1 THERAPEUTIC ANTI-TIRC7 ANTIBODIES FOR USE IN IMMUNE RELATED AND OTHER DISEASES Public/Granted day:2013-12-05
Information query
